Home  >  News
you can get e-magazine links on WhatsApp.Click here
biopol
News
  BioIVT introduces GMP grade human AB serum to facilitate development & manufacturing of cell and gene therapies,   January 27, 2022
  HPV vaccines are reducing cervical cancer but regular screening remains a vital tool: Study,   January 27, 2022
  Australia’s TGA grants provisional registration for Novavax Covid-19 vaccine, Nuvaxovid,   January 21, 2022
  Innovation Norway awards NOK 8.2 mn grant to Targovax for development of TG mutant RAS vaccine,   January 14, 2022
  GSK, Vir Biotech announce US government to purchase additional 600,000 doses of sotrovimab to treat Covid-19,   January 13, 2022
  India Pavilion at Expo 2020 Dubai celebrates 150 crore Covid-19 vaccinations in the country,   January 10, 2022
  US FDA shortens interval for booster dose of Moderna Covid-19 vaccine to five months,   January 10, 2022
  Bio-Techne, Akoya Biosciences partner to develop automated spatial multiomics workflow with industry-leading speed and resolution,   January 07, 2022
  Pfizer, BioNTech ink collaboration to develop first mRNA-based vaccine for prevention of shingles,   January 07, 2022
  Pfizer announces US government to purchase an additional 10 mn treatment courses of its Covid-19 oral therapy, Paxlovid,   January 06, 2022
  US FDA expands EUA of booster dose of Pfizer-BioNTech Covid-19 vaccine to include individuals 12 years of age and older,   January 05, 2022
  Mixing of Covaxin and Covishield induces four times more antibody response, says AIG Hospitals study,   January 04, 2022
  Novavax completes submission of final data packages to US FDA as prerequisite to EUA application request for Covid-19 vaccine,   January 03, 2022
  Moderna announces Switzerland exercises its option to purchase 7 mn additional doses of Moderna's Covid-19 booster vaccine in 2022,   December 29, 2021
  IMA welcomes PM Modi’s decision on precautionary booster dose, paediatric vaccination,   December 27, 2021
  Bharat Biotech's Covaxin receives emergency approval for children 12-18 years of age,   December 27, 2021
  Merck, Ridgeback’s oral antiviral Covid-19 medicine, molnupiravir receives Special Approval for Emergency in Japan,   December 27, 2021
  WHO with support of SAGE & Covid-19 Vaccines Working Group issue interim statement on booster doses for Covid-19 vaccination,   December 24, 2021
  Pfizer inks agreement with UK govt to supply additional 2.5 mn treatment courses of investigational candidate Paxlovid to help combat Covid-19,   December 24, 2021
  SkylineDx, VIB ink strategic partnership in molecular diagnostics,   December 23, 2021

 Back
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |